[Effect on Prognosis of Immune-Related Adverse Events after Nivolumab Treatment in Gastric Cancer].

Tetsushi Kubota,Yasuhiro Choda,Michihiro Ishida,Takuya Yano,Daisuke Sato,Masanori Yoshimitsu,Kanyu Nakano,Masao Harano,Hiroyoshi Matsukawa,Hitoshi Idani,Shigehiro Shiozaki,Masazumi Okajima

Gan to kagaku ryoho. Cancer & chemotherapy（2020）

引用 0|浏览1

暂无评分

摘要

Long-term efficacy is expected with nivolumab, but it may be necessary to recognize that the onset of serious irAEs might make subsequent treatment difficult.

查看译文

关键词

nivolumab treatment,gastric cancer,immune-related

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要